The Valley Desk

NCT05774951 · Interventional trial

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Overall registry status Recruiting

Phase 3

Conditions Breast Cancer, Early Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov